What is in this article?:
- FDA moves to clear up murky nanotechnology guidelines
- Common nanotechnology uses
Despite nanoparticles' widespread use in commercial products, the definition, characterization and regulation of the technology by government bodies had been based on particle size not properties. The FDA's new nanotechnology draft guidance signals a turn toward more accurate classification and rules for use.
Nanotechnology—the reduction of ingredients into nanometer-sized particles—has generated major buzz across myriad commercial industries over the past decade. Lauded for everything from their antimicrobial attributes to their superior sunscreening abilities, nanometer-sized versions of substances like silver, silica, titanium dioxide and zinc oxide, have mounting applications in the manufacture of food, supplements, personal care, pesticides and product packaging.
"There are thousands of commercial products available that employ nanoparticles in some measure," said Colin O'Neil, regulatory policy analyst for the Washington, D.C.-based Center for Food Safety. "They're being used throughout the food industry already, as antimicrobials on cutting boards and in food packaging. A package lined with a nano-sized antimicrobial like silver could allow lettuce to be shipped across the world with reduced risk of contamination. Nanomaterials can also change the color and pigment of materials. The food industry views them as the next level of industrial food processing and manufacture."
Despite their widespread use, the definition, characterization and regulation of nanoparticles by government bodies has been nebulous at best. Government agencies had previously defined nanos by size, but are now finding that chemicals and ingredients with entirely different characteristics shouldn't necessarily be lumped into one category based solely on particle dimensions. "CFS has been advocating against a one-size-fits-all definition of a nanoparticle," O'Neil said.
Besides ineffective classification, a more pressing issue is that many of these tiny particles take on properties and phenomena not seen in their larger counterparts--a crucial factor not initially considered by regulatory bodies. As a result, many of these nanoparticles evaded the usual safety testing that commercially used materials must endure, because particle size hadn't been seen as an issue.
But now it's becoming widely realized that size does indeed matter. "We have proof that nanoparticles are different from their bulk counterparts—that's no longer under debate," O'Neil said. "Now the question is how they'll be regulated."
FDA's new nanotechnology guidance
Last week the FDA issued a draft guidance that seeks to more accurately and adequately define nanoparticles and advise nano-using industries on how to employ them. In "Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology," the agency named characteristics—size and exhibited properties—to be considered when identifying nanoparticles' applications in regulated products.
As this guidance gains traction, it could significantly impact the development, release and use of new consumer and commerical products, such as deodorant that uses nano-sized silica and super-concentrated pesticides that use nano antimicrobials. Manufacturers may be subject to safety testing and guidelines surrounding nanoparticles that they hadn't been previously.